FDA Drug recall D-0595-2024
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distribut…
- FDA Drug
- Class III
- completed
- Published 2024-07-17
On 2024-07-17 the FDA classified a Class III recall of Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distribut… by Zydus Pharmaceuticals Usa, citing cross contamination with other products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0595-2024 |
| Classification | Class III |
| Status | completed |
| Initiated | 2024-07-02 |
| Published | 2024-07-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zydus Pharmaceuticals Usa |
| Distribution | US |
Product
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).
Reason
Cross contamination with other products
Identifiers
| code_info | Lot #: L300220, Exp. 05/31/2025. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0595-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.